Launch of TGA Registered Vaporisers

Launch of TGA Registered Vaporisers

Announcements

SPECTRUM THERAPEUTICS LAUNCHES E-COMMERCE PLATFORM FOR ONLY CANNABINOID VAPORISERS REGISTERED ON THE ARTG

June 3, 2020 Spectrum Therapeutics

VICTORIA, AUSTRALIA – Spectrum Therapeutics Australia (Spectrum), the medical division of Canopy Growth Corporation (Canopy Growth), is pleased to announce the launch of its e-commerce platform featuring the Storz & Bickel Volcano® Medic 2 and the Mighty® Medic vaporisers, the only registered devices on the ARTG, for vaporisation of medicinal cannabinoids. 

 

With a 20-year track record of breakthrough innovations, Storz & Bickel, also owned by Canopy Growth, is internationally known for its design and manufacturing. Storz & Bickel has spent the last two decades developing an automated and internationally certified factory, achieving ISO 13485 certification in 2009. 

 

Storz & Bickel was the first company to manufacture cannabis vapourisers to internationally recognised medical device standards, including the iconic original Volcano Medic, which has been used in cannabis research worldwide for 10 years, and are registered in multiple jurisdictions. 

Spectrum Therapeutics is committed to ensuring a consistent, quality and regulated supply of medicinal cannabis products is accessible to patients in Australia. “When health practitioners are considering dried medicinal cannabis flower as a form of administration, it is important to ensure that registered medical devices, manufactured to stringent medical device standards, are available for patients,”  said Ben Quirin, Asia-Pacific Managing Director, Canopy Growth.

For further information, visit www.vapormed.com.au

 

About Spectrum Therapeutics

Spectrum Therapeutics, the medical division of Canopy Growth Corporation (TSX: WEED, NYSE: CGC), is dedicated to educating healthcare practitioners, furthering the public's understanding of medical cannabis and its various applications, and cutting edge, commercialisable research and IP development. Founded in Canada, Spectrum Therapeutics operates in Australia, South America, Africa and across Europe. Its products are available in a wide range of potencies and formats designed to simplify the dialogue around strength and dosage by applying a colour-coded spectrum to categorise medical cannabis according to THC and CBD levels.

Spectrum Therapeutics' offerings include whole flower cannabis, oils and new innovations such as Softgels in addition to single cannabinoid medicine Dronabinol under the brand Bionorica Ethics. Through product simplification, robust clinical research and ongoing education of healthcare professionals, Spectrum Therapeutics is committed to addressing the unmet medical needs of patients around the globe.

This website uses cookies to recognize your computer or device to give you the best user experience and to improve its features. You can disable cookies through your browser but some features of the site will no longer be available. To read our Website Privacy Statement, click here.